Endevica Bio drug candidate shows success in weight loss in new study

NORTHBROOK, Ill., April 23, 2024 - Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was successful in a recent diet-induced obesity (DIO) rat study. This latest research solidifies...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials